171 related articles for article (PubMed ID: 17160101)
1. Contribution of the regional drug information center towards drug safety.
Palaian S; Mishra P; Shankar PR; Bista D; Purwar B
JNMA J Nepal Med Assoc; 2006; 45(161):216-8. PubMed ID: 17160101
[TBL] [Abstract][Full Text] [Related]
2. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
Jimmy B; Jose J; Rao PG
Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
[TBL] [Abstract][Full Text] [Related]
3. [Medical drug information in the database Drugline].
Alván G; Ohman B; Sjöqvist F
Lakartidningen; 1989 Apr; 86(17):1607-8. PubMed ID: 2725149
[TBL] [Abstract][Full Text] [Related]
4. Regional drug information service.
Schwarz UI; Stoelben S; Ebert U; Siepmann M; Krappweis J; Kirch W
Int J Clin Pharmacol Ther; 1999 Jun; 37(6):263-8. PubMed ID: 10395116
[TBL] [Abstract][Full Text] [Related]
5. Drug information needs of physicians treating diabetic nephropathy in a tertiary care hospital.
Devi P; George J
Kathmandu Univ Med J (KUMJ); 2008; 6(1):23-7. PubMed ID: 18604110
[TBL] [Abstract][Full Text] [Related]
6. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
P S; P M; Pr S
Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of drug information inquiries in an Ethiopian university hospital: A two-year observational study.
Tefera YG; Gebresillassie BM; Ayele AA; Belay YB; Emiru YK
Sci Rep; 2019 Sep; 9(1):13835. PubMed ID: 31554837
[TBL] [Abstract][Full Text] [Related]
8. [A regional center for reporting adverse drug reactions in Umeå. Prompt handling results in quick feedback].
Bäckström M; Dahlqvist R; Mjörndal T; Spigset O; Hedenmalm K; Granberg K; Oqvist U; Wiholm BE
Lakartidningen; 1995 Jan; 92(3):148-50. PubMed ID: 7837847
[No Abstract] [Full Text] [Related]
9. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
[TBL] [Abstract][Full Text] [Related]
10. Obstetric drug information service.
Arulappu RG; Taylor DJ
Am J Hosp Pharm; 1982 Sep; 39(9):1511-4. PubMed ID: 7137189
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
12. Adverse drug reactions in childhood: a review of prospective studies and safety alerts.
Clavenna A; Bonati M
Arch Dis Child; 2009 Sep; 94(9):724-8. PubMed ID: 19531524
[TBL] [Abstract][Full Text] [Related]
13. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
Page RL; Ruscin JM
Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
Jha N; Bajracharya O; Namgyal T
Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
[TBL] [Abstract][Full Text] [Related]
15. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
16. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
17. European survey of independent drug information centers.
Taggiasco N; Sarrut B; Doreau CG
Ann Pharmacother; 1992 Mar; 26(3):422-8. PubMed ID: 1554964
[TBL] [Abstract][Full Text] [Related]
18. Hospital pharmacists' activities and attitudes regarding the Thai safety monitoring program for new drugs.
Jarernsiripornkul N; Krska J; Pongmanachai M; Nasritha N
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):837-41. PubMed ID: 19548223
[TBL] [Abstract][Full Text] [Related]
19. Applying quantitative methods for detecting new drug safety signals in pharmacovigilance national database.
Shalviri G; Mohammad K; Majdzadeh R; Gholami K
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1136-40. PubMed ID: 17705214
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
